Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

Not yet recruiting

Conditions: Melanoma Stage III or IV

Interventions: Diagnostic Test: Lead ECG
Diagnostic Test: Transthoracic Echocardiogram
Diagnostic Test: Cardiac MRI
Diagnostic Test: Cardiac Biomarker Screening
Other: Basic Observations

First Posted Date: 2024-09-20

Last Posted Date: 2025-06-27

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 60

Registration Number: NCT06605833

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting

Active, not recruiting

Conditions: Cancer, Breast

Interventions: Procedure: Mammography Images

First Posted Date: 2024-08-30

Last Posted Date: 2024-08-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 25000

Registration Number: NCT06578988

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Preoperative Planning With PSMA-PET in Melanoma Surgery Trial

Phase 2

Recruiting

Conditions: Malignant Melanoma

Interventions: Drug: 68Ga-PSMA

First Posted Date: 2024-08-19

Last Posted Date: 2025-07-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 16

Registration Number: NCT06560905

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

Prophylactic Prostatectomy for Prostate Cancer (PPPC)

Conditions: Prostate Cancer
BRCA Mutation
Genetic Predisposition to Disease

First Posted Date: 2024-06-24

Last Posted Date: 2025-03-27

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 20

Registration Number: NCT06470685

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

LATe TreatmENT Related Toxicity in Melanoma (LATENT)

Not yet recruiting

Conditions: Melanoma

First Posted Date: 2024-05-16

Last Posted Date: 2024-06-25

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 400

Registration Number: NCT06414343

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, Chelsea, London, United Kingdom

The Man Van Project

Not Applicable

Recruiting

Conditions: Prostate Cancer
Urologic Cancer
Urologic Diseases
Testis Cancer
Bladder Cancer
Renal Cancer
Hypertension
Alcoholism
Diabetes
Mental Health Issue

Interventions: Other: Main Man Van Group Sub-study (MV-Eco)
Other: MV-QualQ Sub-study
Device: MV-POCT Sub-study
Diagnostic Test: MV-PRS Sub-study
Other: MV-DNA and MV-UctDNA Sub-study
Other: MV-SSI Sub-study
Other: Man Van patients
Other: MV-TPP Sub-study

First Posted Date: 2024-04-10

Last Posted Date: 2024-05-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 4000

Registration Number: NCT06357416

Locations: 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

Mapping Arterial Perforators Within the Breast During Mammoplasty

Completed

Conditions: Breast Cancer

First Posted Date: 2024-04-04

Last Posted Date: 2024-04-04

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 80

Registration Number: NCT06347952

Locations: 🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom

The Role of tHyroid cAncer Specific Patient Concerns iNventory (PCI-TC) in Enhancing Shared decisiOn Making

Recruiting

Conditions: Thyroid Cancer

Interventions: Other: Interview

First Posted Date: 2024-03-20

Last Posted Date: 2024-08-09

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 32

Registration Number: NCT06322160

Locations: 🇬🇧
Guys & St Thomas, London, United Kingdom
🇬🇧
UCLH, London, United Kingdom

Peri-operative Zimberelimab vs Zimberelimab in Comb With Domvanalimab in Resectable Mismatch Repair Deficient/Micro-satellite Unstable Gastric & Gastro-oesophageal Junctional Adenocarcinoma (ZODIAC)

Phase 2

Recruiting

Conditions: Locally Advanced Gastric Adenocarcinoma
MSI-H/dMMR Gastric Cancer
MSI-H/dMMR Gastroesophageal-junction Cancer

Interventions: Drug: Single agent zimberelimab
Drug: Combination zimberelimab + domvanalimab

First Posted Date: 2024-02-08

Last Posted Date: 2025-05-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 50

Registration Number: NCT06250036

Locations: 🇬🇧
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
🇬🇧
St Bartholomew's Hospital, London, United Kingdom
🇬🇧
Ninewells hospital and Medical School, Dundee, United Kingdom

and more 1 locations

Inherited Cancer Early Diagnosis (ICED) Study

Recruiting

Conditions: Li Fraumeni Syndrome
MutYH-associated Polyposis
Peutz-Jeghers Syndrome
SMAD4 Gene Mutation
Lynch Syndrome
Hereditary Diffuse Gastric Cancer
Familial Adenomatous Polyposis
Cowden Syndrome

First Posted Date: 2023-12-08

Last Posted Date: 2023-12-08

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 100

Registration Number: NCT06163365

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy